Biomedical Technology,
Journal Year:
2024,
Volume and Issue:
7, P. 1 - 14
Published: June 5, 2024
Cardiovascular
disease
(CVD)
remains
a
leading
cause
of
mortality
worldwide,
claiming
countless
lives
and
posing
formidable
health
challenge.
Extensive
efforts
have
been
dedicated
to
combating
this
disease,
including
the
development
innovative
biomaterials
for
blood
vessel
stents,
drug
delivery
imaging
diagnosis.
These
advancements
substantially
addressed
issues
such
as
patient
rejection
contamination.
In
review,
we
begin
by
outlining
prevalence
various
forms
CVD.
Subsequently,
delve
into
advanced
biomaterials—including
synthetic
biomaterials,
natural
hybrid
biomaterials—and
medical
instruments
used
in
treatment
or
alleviation
CVD,
discussing
their
advantages
limitations.
Finally,
offer
insights
future
prospects
strategies
refining
these
technologies
moving
forward.
Advanced Healthcare Materials,
Journal Year:
2022,
Volume and Issue:
12(16)
Published: Nov. 15, 2022
Abstract
Since
the
2010s,
demand
for
healthcare
models
has
exceeded
prevailing
resources
available
due
to
rapid
increase
in
aging
population
China.
However,
a
significant
gap
development
of
biomedical
materials
remains,
especially
between
China
and
western
developed
countries.
Collagen
is
major
protein
extracellular
matrix
(ECM)
been
extensively
applied
medical
fields.
Collagen‐based
biomaterials
(CBBs)
are
used
prepare
dressings
dermal
substitutes,
surgical
sutures,
plasma
tissue‐engineered
scaffolds,
drug
delivery
systems;
this
attributed
their
exceptional
biocompatibility,
biodegradability,
hypoimmunogenicity,
coordination
collagen
hosts
tissues.
This
review
provides
thorough
strides
CBB
structures,
crosslinking
forming
technologies,
real‐world
applications.
First,
natural
origin
specific
structures
animal‐derived
non‐animal‐derived
introduced
compared.
Second,
methods
technologies
CBBs
across
board
discussed.
Third,
several
examples
considered
demonstrate
practical
use
highlight
cautionary
notes.
Finally,
underlying
directions
from
an
interdisciplinary
perspective
outlined.
aims
provide
comprehensive
mechanisms
by
which
can
be
uniquely
practically
as
advanced
biomaterial,
hence
providing
options
augmenting
its
Journal of the American Chemical Society,
Journal Year:
2023,
Volume and Issue:
145(32), P. 17881 - 17891
Published: Aug. 2, 2023
Atherosclerotic
plaque
rupture
is
a
significant
cause
of
acute
cardiovascular
events
such
as
heart
attack
and
stroke,
triggered
by
the
decomposition
fiber
caps
induced
cysteine
cathepsin.
However,
accurate
measurement
cathepsin
B
(CTB)
activity
in
plaques
challenging
due
to
low
specificity
insufficient
penetration
depth
available
atherosclerosis-associated
fluorescent
probes,
hampering
reliable
assessment
vulnerability.
To
address
these
limitations,
we
added
both
lipophilic
alkyl
chain
hydrophilic
CTB
substrate
hemicyanine
scaffold
develop
lipid-unlocked
responsive
probe
(L-CRP)
that
uses
lipids
two
keys
unlock
photoacoustic
(PA)
signals
for
measuring
environments.
Such
properties
allow
L-CRP
imaging
specific
activities
foam
cells
atherosclerotic
while
keeping
silence
toward
lipid-deficient
environments,
M1-type
macrophages
LPS-induced
inflammatory
lesions.
Moreover,
activatable
PA
exhibit
deeper
tissue
ability
(>1.0
cm)
than
current
probes
based
on
near-infrared
(∼0.3
cm),
suitable
atherosclerosis
living
mice.
In
mice,
dynamically
reports
intraplaque
levels,
which
well-correlated
with
vulnerability
characteristics
cap
thickness,
macrophage
recruitment,
necrotic
core
size,
thus
enabling
risk
stratification
mice
complicated
pneumonia.
successfully
identifies
excised
human
artery
tissues,
promising
auxiliary
diagnosis
clinical
application.
Advanced Healthcare Materials,
Journal Year:
2023,
Volume and Issue:
12(19)
Published: March 13, 2023
Heart
failure
(HF)
affects
60
million
people
worldwide
and
has
developed
into
a
global
public
health
problem
surpassing
cancer
urgently
needs
to
be
solved.
According
the
etiological
spectrum,
HF
due
myocardial
infarction
(MI)
become
dominant
cause
of
morbidity
mortality.
Possible
treatments
include
pharmacology,
medical
device
implantation,
cardiac
transplantation,
which
are
limited
in
their
ability
promote
long-term
functional
stabilization
heart.
Injectable
hydrogel
therapy
emerged
as
minimally
invasive
tissue
engineering
treatment
approach.
Hydrogels
can
provide
necessary
mechanical
support
for
infarcted
myocardium
serve
carriers
various
drugs,
bioactive
factors,
cells
improve
cellular
microenvironment
region
induce
regeneration.
Herein,
pathophysiological
mechanism
is
explored
injectable
hydrogels
potential
solution
current
clinical
trials
applications
summarized.
Specifically,
hydrogels,
decellularized
ECM
variety
biotherapeutic
agent-loaded
conductive
repair
were
discussed,
action
these
hydrogel-based
therapies
was
emphasized.
Finally,
limitations
future
prospects
post
MI
proposed
inspire
novel
therapeutic
strategies.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Jan. 25, 2024
Abstract
Drug-eluting
stent
implantation
suppresses
the
excessive
proliferation
of
smooth
muscle
cells
to
reduce
in-stent
restenosis.
However,
efficacy
drug-eluting
stents
remains
limited
due
delayed
reendothelialization,
impaired
intimal
remodeling,
and
potentially
increased
late
Here,
we
show
that
a
drug-free
coating
formulation
functionalized
with
tailored
recombinant
humanized
type
III
collagen
exerts
one-produces-multi
effects
in
response
injured
tissue
following
implantation.
We
demonstrate
possesses
anticoagulation,
anti-inflammatory,
hyperplasia
suppression
properties.
perform
transcriptome
analysis
indicate
favors
endothelialization
process
induces
conversion
contractile
phenotype.
find
compared
stents,
our
reduces
restenosis
rabbit
porcine
models
improves
vascular
neointimal
healing
model.
Collectively,
system
represents
promising
strategy
for
next-generation
stents.
Advanced Functional Materials,
Journal Year:
2023,
Volume and Issue:
33(30)
Published: April 26, 2023
Abstract
Vascular
restenosis
after
balloon
dilation
is
largely
caused
by
the
over‐proliferation
of
smooth
muscle
cells,
which
triggered
and
exacerbated
local
excessive
inflammation
oxidative
stress.
The
inflammatory
stress
cause
tissue/cell
damage,
hamper
endothelial
functions,
worsen
intimal
hyperplasia
restenosis.
A
high
level
reactive
oxygen
species
(ROS)
overproduction
regarded
as
main
culprit.
Therefore,
efficiently
inhibiting
ROS
over‐production
or
weightily
depleting
them
great
significance.
Herein,
a
“ROS‐responsive/scavenging
prodrug”
introduced
into
coating
for
treatment
vascular
reversible
phenylboronic
ester‐bearing
caffeic
acid
(CA)
macromolecular
prodrug
(PBC)
designed
controlled
on‐demand
dual‐drug
release
level;
released
CA
4‐hydroxybenzyl
alcohol
exhibit
efficient
antioxidant
anti‐inflammatory
effects
scavenging
ROS,
thereby
regulating
microenvironment
protecting
endothelium
functions.
To
accelerate
regeneration,
pro‐endothelial
microRNA‐126
further
introduced.
ROS‐responsive/scavenging
prodrug/miRNA
prevents
hyperplasia,
alleviates
inflammation,
improves
healing
in
rat
abdominal
aorta
model,
may
provide
applicative
perspectives
next‐generation
drug‐coated
balloons
other
cardiovascular
diseases
treatment.
Journal of Nanobiotechnology,
Journal Year:
2023,
Volume and Issue:
21(1)
Published: Aug. 26, 2023
Myocardial
infarction
(MI)
is
a
cardiovascular
emergency
and
the
leading
cause
of
death
worldwide.
Inflammatory
immune
responses
are
initiated
immediately
after
MI,
to
myocardial
death,
scarring,
ventricular
remodeling.
Current
therapeutic
approaches
emphasize
early
restoration
ischemic
reperfusion,
but
there
no
effective
treatment
for
pathological
changes
infarction.
Biomedical
materials
development
has
brought
new
hope
MI
diagnosis
treatment.
materials,
such
as
cardiac
patches,
hydrogels,
nano
biomaterials,
artificial
blood
vessels,
have
played
an
irreplaceable
role
in
They
improve
accuracy
efficacy
offer
further
possibilities
reducing
inflammation,
immunomodulation,
inhibiting
fibrosis,
regeneration.
This
review
focuses
on
advances
biomedical
applications
The
current
studies
outlined
terms
mechanisms
action
effects.
It
addressed
how
application
can
lessen
damage,
encourage
angiogenesis,
enhance
heart
function.
Their
clinical
transformation
value
prospect
discussed.
Advanced Healthcare Materials,
Journal Year:
2023,
Volume and Issue:
13(8)
Published: Dec. 20, 2023
Surfaces
with
biological
functionalities
are
of
great
interest
for
biomaterials,
tissue
engineering,
biophysics,
and
controlling
processes.
The
layer-by-layer
(LbL)
assembly
is
a
highly
versatile
methodology
introduced
30
years
ago,
which
consists
assembling
complementary
polyelectrolytes
or
biomolecules
in
stepwise
manner
to
form
thin
self-assembled
films.
In
view
its
simplicity,
compatibility
molecules,
adaptability
any
kind
supporting
material
carrier,
this
technology
has
undergone
major
developments
over
the
past
decades.
Specific
applications
have
emerged
different
biomedical
fields
owing
possibility
load
immobilize
preserved
bioactivity,
use
an
extremely
broad
range
carriers,
modify
film's
mechanical
properties
via
crosslinking.
review,
focus
on
recent
regarding
LbL
films
formed
as
2D
3D
objects
drug
delivery
engineering.
Possible
vaccinology,
biomimetic
models,
well
bone
cardiovascular
engineering
highlighted.
addition,
most
technological
field
film
construction,
such
high-content
liquid
handling
machine
learning,
expected
open
new
perspectives
future
LbL,
presented.